Ellie Chabi, MD is the Therapeutic Area Head for Glaucoma & Neuroprotection as well as the Lead for Artificial Intelligence Programs within Global Biomedical Science at Santen. Prior to joining Santen, she was at Genentech in late-stage ophthalmology. Ellie began her pharmaceutical career at Merck in the Neuroscience & Ophthalmology Clinical Research Group, working on a range of projects within Ophthalmology as well as Neuroscience. In addition to experiences in drug and device development, Ellie has been extensively involved in due diligences for Business Development and Venture Capital teams. She is currently serving as a board observer for several companies. Ellie received her undergraduate and medical school education at the University of Wisconsin. In addition to residency training in ophthalmology and surgical fellowship training in Cornea & External Disease, she completed an ophthalmology research fellowship at Cornell University as well as a bioentrepreneurship program at the University of California-San Francisco and Aresty Scholar Executive Education program at Wharton.